DJESA: awareness-raising and interdisciplinarity in medical education
On Friday, March 1, the Faculty of Medicine hosted a Half Day of Exchange on Food Sovereignty (DJESA), organized by the UNI4COOP consortium, Humundi and Vétérinaires Sans Frontières. Led by Professor Grégoire Wiëers, Director of UNamur's Department of Medicine, and Caroline Canon, Master of Didactics, this event was dedicated to Block 2 students in medicine, pharmacy and biomedical sciences. An afternoon punctuated by a gesticulated lecture by Corentin Hecquet and awareness-raising workshops on sustainable development and interdisciplinarity in the medical field..
See content
ERAMET project launched: improving the drug regulation system
On March 4 and 5, UNamur hosted the launch event for the European ERAMET project. Led by Professor Flora Musuamba Tshinanu, this collaborative project brings together 17 European partners. Objective: to improve the scientific database guiding regulators in drug evaluation, with a focus on rare and pediatric conditions. A look back at the launch day.
See content
An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart
On 13 December 2023, Charlotte Beaudart, a new academic at the University of Namur Faculty of Medicine, will be awarded a prize at the annual ceremony for Belgian scientific research in support of her innovative research on the subject of ageing.
See content
Rural medicine: the UNamur inaugurates a university observatory
This is a first in the Belgian medical and academic landscape: a university observatory for rural medicine has been set up at the University of Namur. Its mission is to understand the shortage of doctors in rural areas and identify solutions, in collaboration with local stakeholders, to encourage future GPs to set up in these regions.
See content
The Teddy Bear Clinic: pharma students demystify the medical world for children
On their own initiative, five masters’ students from the UNamur pharmacy department slipped into the shoes of 'Teddybearologists' as part of the 'Teddy Bear Clinic', an event organised by UCLouvain. They played the role of pharmacists, recommending treatments for children's teddy bears and explaining the role of their future profession.
See content
Medical students take action to raise awareness of alcohol consumption
From 13 to 17 March 2023, the Cercle Médecine is organising a week to raise awareness of addiction and alcohol consumption. Various activities are proposed. The organisers want to make some students aware of their consumption.
See content
Specialization in general medicine: the UNamur, supported by professionals in the sector, claims its necessity
On Thursday March 16, 2023, the Government of the Wallonia-Brussels Federation debated the file of authorization requests for higher education. The UNamur reveals elements supporting the merits of its request to organize specialization in medicine general. Six questions to better understand.
See content
Open morning
Take part in our open morning
Given the works in the rue de Bruxelles and the renovation of part of the University parking lots, we invite you to use public transport whenever possible (train or bus) to reach Namur. UNamur boasts an ideal location, in the heart of the city just a five-minute walk from the TEC and SNCB train stations.If you're coming by car, take a look at the parking map provided.
Look forward to seeing you on Saturday, June 29!
See content
Public thesis defense - Pauline TRICQUET
The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.
See content
Contact
On this page you will find the various people to contact within the Faculty of Medicine.
See content
Public defense of doctoral thesis - Julien FAVRESSE
COVID-19 is an infectious disease caused by SARS-CoV-2. COVID-19 was quickly declared a pandemic by the World Health Organization (WHO) on March 11, 2020.At the start of the pandemic, healthcare professionals were faced with the marketing of numerous kits designed to measure binding antibodies. The role of neutralizing antibodies as the best correlate of protection against SARS-CoV-2 infection was quickly highlighted. A neutralization assay with the use of pseudovirus was therefore developed by our team and compared with several binding assays.There have been considerable efforts to produce and clinically validate new vaccines against COVID-19. The CRO-VAX HCP study was designed to assess the humoral response in a population of healthcare professionals who had received two doses of COVID-19 BNT162b2 vaccine.Given the decline in vaccine efficacy over time and the emergence of variants likely to evade immunity, a third dose was quickly recommended by the authorities to boost immunity. This was administered to 155 volunteers in the CRO-VAX HCP study.Still facing a decline in vaccine efficacy over time and the emergence of new variants, a second adapted booster was proposed. In September 2022, 54 participants in the CRO-VAX HCP study received this second booster. The humoral response was assessed and neutralizing antibodies against several variants were measured. In addition, we also measured the cellular response using an interferon-gamma release assay. Compared with the humoral response, which declines considerably over time, the cellular response remained fairly stable. This could therefore explain why individuals with low antibody titers can still be protected against a severe form of the disease .
See content
Academic year 2024-2025
On the program for all
The start of the 2024-2025 academic year will take place on September 16, 2024.09:30 | Welcome ceremony at the Vauban amphitheater (Bd Frère Orban - 5000 Namur).11:00 | Back-to-school celebration at Saint-Aubain Cathedral (Place Saint-Aubain - 5000 Namur) then welcome students by the Cercles.
Read more
Les infos des paragraphes suivants concernent l'année académique 2024-2025 - elles seront mises à jour prochainement !
First year bachelor
Monday, September 162pm-3pm - VAUBAN auditorium : Welcome from the Dean and Vice-Dean: Pr. Jean-Michel Dogné and Pr. Nathalie Kirschvink Presentation of the various departments of the faculty Bachelor of Medicine 3pm - VAUBAN auditorium : Information session for students of the 1st Bachelor of Medicine by the Department Head in Medicine, Pr. Grégoire Wieërs. Bachelor in Pharmaceutical Sciences 3pm - auditorium PA01 (Pedro Arrupe) : Information session for students of the 1st Bachelor in Pharmaceutical Sciences by the pedagogical coordinator in Pharmaceutical Sciences, Mr. Romain Siriez. Bachelor in Biomedical Sciences 3pm - auditorium PA02 (Pedro Arrupe) : Information session for students of the 1st Bachelor in Biomedical Sciences by the Department Director in Biomedical Sciences, Prof. Jean-Pierre Gillet. Attendance at these sessions is compulsory. A student guide will be available on the Bureau Virtuel de l'Etudiant (BVE). From September 17, 2024, classes resume according to a specific timetable (the schedule for the 1st quadrimester will be posted at the valves on September 9). Practical work (TP/TD) does not start for 2 weeks; schedules and groups will be posted in due course. Course salesA course sales schedule will be available on your Virtual Student Office (VSO): bookstores will be open to all at the start of the new school year.
See content